Sign Up to like & get
recommendations!
1
Published in 2018 at "Pediatrics"
DOI: 10.1542/peds.2018-2420qqqq
Abstract: A Esquivel, WW Busse, A Calatroni. Am J Respir Crit Care Med. 2017;196(8):985–992 To evaluate whether inhibiting immunoglobulin E (IgE), via omalizumab, would reduce the frequency and duration of rhinovirus (RV) illness in children with…
read more here.
Keywords:
effects omalizumab;
study;
illnesses exacerbations;
omalizumab rhinovirus ... See more keywords